1Garvey M J, Hollon SD. Evans MD. Examination of pre-and posttreatment MHPG during cognitive therapy [ J ] . Neuropsychobiology, 1992, 26 (4) : 182 - 185.
2Kobayashi K, Shimizu E, Hashimoto K, et al. Serum brainderived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behav.ioral therapy [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29 (5) : 658 - 663.
4Cruess DG, Antoni MH, McGregor BA, et al. Cognitive-behavioral stress management reduces serum Cohisol by enhancing benefit finding among women being treated for early stage breast cancer [ J ] . Psychosom Med, 2000, 62 (3) : 304 - 308.
5Antoni MH. Stress management effects on psychological, endocrinological, and immune functioning in men with HIV infection: empirical support for a psychoneuroimmunological model [J] . Stress, 2003, 6 (3): 173-188.
6Abelson JL, Liberzon I, Young EA, et al. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects [ J] . Arch Gen Psychiatry, 2005, 62 (6) : 668 -675.
7Sobrinho LG, Sire? es M, Barbosa L, et al. Cohisol, prolactin, growth hormone and neurovegetative responses to emotions elicited during an hypnoidal state [ J] . Psychoneuroendocrinology, 2003, 28 (1): 1- 17.
8Doering LV, Cross R, Vredevoe D, et al. hffection, depression, and immunity in women after Colonary artery bypass: a pilot study of cognitive behavioral therapy [ J ] . Altern Ther Health Med, 2007, 13 (3) : 18 -21.
9Savard J, Simard S, Ivers H, et al. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part Ⅱ: Immunologic effects [ J] .J Clin Oncol, 2005, 23 (25): 6097-6106.
10McGregor BA, Antoni MH, Boyers A, et al. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer [J] . JPsychosomRes, 2004, 56 (1): 1-8.